Across TCGA pan-cancer cohorts, RNA5SP321 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNA5SP321 data layer.
The strongest signal is observed in thymoma (THYM), where higher RNA5SP321 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP321 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.
THYM, KICH, and CESC are the cancer types where RNA5SP321 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.